The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.
Menu
Ambulatory infusion pump sets for use in the United States are in limited supply. NHIA has developed product shortage recommendations to help clinicians manage patients during this time when pump sets may not be readily available.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.